📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson's disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study. (2020)

First Author: Payne T

Attributed to: In vivo pathway analysis to determine the mechanistic role of susceptibility genes for Parkinson's disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2020-038911

PubMed Identifier: 32759251

Publication URI: http://europepmc.org/abstract/MED/32759251

Type: Journal Article/Review

Volume: 10

Parent Publication: BMJ open

Issue: 8

ISSN: 2044-6055